Table 3. Codes for influenza vaccine used in analysis of MarketScan data for immunosuppressive conditions and hospitalizations for acute respiratory illness, United States.
| CPT no.* | Vaccine type |
|---|---|
| 90653 | Influenza virus vaccine, inactivated, subunit, adjuvanted, for intramuscular use |
| 90654 | influenza, seasonal, intradermal, preservative free |
| 90655 | Influenza virus vaccine, split virus, no preservative, for children 6–35 mo of age, for intramuscular use |
| 90656 | Influenza virus vaccine, split virus, no preservative, for use in persons >3 y of age, for intramuscular use |
| 90657 | Influenza virus vaccine, split virus, for children 6–35 mo of age, for intramuscular use |
| 90658 | Influenza virus vaccine, split virus, for use in persons >3 y of age, for intramuscular use |
| 90659 | Influenza, whole |
| 90660 | Influenza virus vaccine, live, for intranasal use |
| 90661 | Influenza virus vaccine, derived from cell cultures, subunit, preservative and antimicrobial drug free, for intramuscular use |
| 90662 | Influenza, high dose seasonal |
| 90663 | Influenza virus vaccine, pandemic H1N1 |
| 90664 | Influenza virus vaccine, pandemic formulation, live, for intranasal use |
| 90666 | Influenza virus vaccine, pandemic formulation, split virus, preservative free, for intramuscular use |
| 90667 | Influenza virus vaccine, pandemic formulation, split virus, adjuvanted, for intramuscular use |
| 90668 | Influenza virus vaccine, pandemic formulation, split virus, for intramuscular use |
| 90724 | Influenza, unspecified formulation |
| 90470 | H1N1 immunization administration (intramuscular, intranasal) |
| 90672 | Influenza virus vaccine, quadrivalent, live, for intranasal use |
| 90673 | Influenza virus vaccine, trivalent, derived from recombinant DNA (recombinant influenza vaccine 3), hemagglutnin protein only, preservative and antimicrobial drug free, for intramuscular use |
| 90685 | Influenza virus vaccine, quadrivalent, split virus, preservative free, when administered to children 6–35 mo of age, for intramuscular use |
| 90686 | Influenza virus vaccine, quadrivalent, split virus, preservative free, when administered to children >3 y of age, for intramuscular use |
| 90687 | Influenza virus vaccine, quadrivalent, when administered to children 6–35 mo of age, for intramuscular use (not recognized by Medicare) |
| 90688 | Influenza virus vaccine, quadrivalent, when administered to persons >3 y, for intramuscular use (not recognized by Medicare) |
*CPT, Current Procedural Terminology.